{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:21:46Z","timestamp":1762867306587,"version":"3.40.5"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.dld.2017.12.018","type":"journal-article","created":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T13:25:54Z","timestamp":1514381154000},"page":"370-377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6862-1896","authenticated-orcid":false,"given":"Soon Sun","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4792-8335","authenticated-orcid":false,"given":"Hyo Jung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Ji","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae Ryong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob R.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Hong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Jae","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Gyo","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SooJin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Youn","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Won","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2017.12.018_bib0005","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/hepr.12649","article-title":"Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non-alcoholic fatty liver disease with none-to-mild obesity and liver fibrosis","volume":"46","author":"Fujimori","year":"2016","journal-title":"Hepatol Res"},{"key":"10.1016\/j.dld.2017.12.018_bib0010","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2169\/internalmedicine.55.5288","article-title":"Significance of hepatic insulin clearance in patients with chronic hepatitis C and non-alcoholic fatty liver disease","volume":"55","author":"Miyaaki","year":"2016","journal-title":"Intern Med"},{"key":"10.1016\/j.dld.2017.12.018_bib0015","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.atherosclerosis.2008.09.012","article-title":"Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome","volume":"204","author":"Kim","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.dld.2017.12.018_bib0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000165360","article-title":"Serum leptin as a predictor of fatty liver in 7-year-old Korean children","volume":"53","author":"Kim","year":"2008","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.dld.2017.12.018_bib0025","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3949\/ccjm.75.10.721","article-title":"Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome","volume":"75","author":"Kim","year":"2008","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.dld.2017.12.018_bib0030","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.dld.2015.08.004","article-title":"Epidemiological modifiers of non-alcoholic fatty liver disease: focus on high-risk groups","volume":"47","author":"Non-alcoholic Fatty Liver Disease Study Group","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2017.12.018_bib0035","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/sji.12397","article-title":"Effect of lipopolysaccharide on the progression of non-alcoholic fatty liver disease in high caloric diet-fed mice","volume":"83","author":"Matsushita","year":"2016","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.dld.2017.12.018_bib0040","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1111\/febs.13385","article-title":"A novel NAD(P)H-dependent carbonyl reductase specifically expressed in the thyroidectomized chicken fatty liver: catalytic properties and crystal structure","volume":"282","author":"Fukuda","year":"2015","journal-title":"FEBS J"},{"key":"10.1016\/j.dld.2017.12.018_bib0045","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.metabol.2008.03.017","article-title":"Proteomic analysis of fructose-induced fatty liver in hamsters","volume":"57","author":"Zhang","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.dld.2017.12.018_bib0050","article-title":"Nuclear receptor-mediated alleviation of alcoholic fatty liver by polyphenols contained in alcoholic beverages","volume":"9","author":"Yao","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2017.12.018_bib0055","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.diabet.2016.04.002","article-title":"Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: causal association or epiphenomenon?","volume":"42","author":"Targher","year":"2016","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.dld.2017.12.018_bib0060","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1210\/jc.2004-0165","article-title":"Metabolic and body composition factors in subgroups of obesity: what do we know","volume":"89","author":"Karelis","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.dld.2017.12.018_bib0065","doi-asserted-by":"crossref","first-page":"562","DOI":"10.2337\/dc07-1526","article-title":"Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects","volume":"31","author":"Musso","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dld.2017.12.018_bib0070","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1586\/17474124.2015.1007955","article-title":"Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications","volume":"9","author":"Ballestri","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2017.12.018_bib0075","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/liv.12912","article-title":"The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals","volume":"36","author":"Fukuda","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2017.12.018_bib0080","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.dld.2015.10.027","article-title":"A systems medicine approach to the study of non-alcoholic fatty liver disease","volume":"48","author":"Petta","year":"2016","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2017.12.018_bib0085","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.dld.2017.01.147","article-title":"AISF position paper on nonalcoholic fatty liver disease (NAFLD): updates and future directions","volume":"49","author":"Italian Association for the Study of the Liver","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2017.12.018_bib0090","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","author":"WHO Expert Consultation","year":"2004","journal-title":"Lancet"},{"year":"2000","series-title":"The Asia-Pacific perspective: redefining obesity and its treatment","author":"WHO International Association for the Study of Obesity","key":"10.1016\/j.dld.2017.12.018_bib0095"},{"key":"10.1016\/j.dld.2017.12.018_bib0100","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/MEG.0000000000000736","article-title":"Transient remission of nonalcoholic fatty liver disease decreases the risk of incident type 2 diabetes mellitus in Japanese men","volume":"28","author":"Fukuda","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2017.12.018_bib0105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.dld.2017.12.018_bib0110","article-title":"External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2017.12.018_bib0115","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001682","article-title":"Validation of the fatty liver index for nonalcoholic fatty liver disease in middle-aged and elderly Chinese","volume":"94","author":"Huang","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl. 1","key":"10.1016\/j.dld.2017.12.018_bib0120","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc13-S011","article-title":"Standards of medical care in diabetes\u20132013","volume":"36","author":"American Diabetes Association","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dld.2017.12.018_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-137-1-200207020-00006","article-title":"Updated definitions of healthy ranges for serum alanine aminotransferase levels","volume":"137","author":"Prati","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2017.12.018_bib0130","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2017.12.018_bib0135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5009\/gnl14444","article-title":"Prevalence and factors associated with nonalcoholic fatty liver disease in a nonobese Korean population","volume":"10","author":"Cho","year":"2016","journal-title":"Gut Liver"},{"key":"10.1016\/j.dld.2017.12.018_bib0140","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jhep.2010.09.037","article-title":"Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity","volume":"54","author":"Fracanzani","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2017.12.018_bib0145","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.2337\/dc07-0792","article-title":"Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men","volume":"30","author":"Shibata","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dld.2017.12.018_bib0150","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1464-5491.2008.02410.x","article-title":"Fatty liver is an independent risk factor for the development of type 2 diabetes in Korean adults","volume":"25","author":"Kim","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.dld.2017.12.018_bib0155","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1440-1746.2009.05998.x","article-title":"Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup","volume":"25","author":"Yamada","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2017.12.018_bib0160","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2337\/dc10-1991","article-title":"Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study","volume":"34","author":"Bae","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dld.2017.12.018_bib0165","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/hep.26183","article-title":"Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men: 5-year prospective cohort study","volume":"57","author":"Park","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2017.12.018_bib0170","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2337\/dc11-1853","article-title":"Combined influence of insulin resistance, overweight\/obesity, and fatty liver as risk factors for type 2 diabetes","volume":"35","author":"Sung","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dld.2017.12.018_bib0175","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1440-1746.2012.07264.x","article-title":"Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus","volume":"28","author":"Kasturiratne","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2017.12.018_bib0180","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1038\/ajg.2013.349","article-title":"Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population","volume":"108","author":"Chang","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2017.12.018_bib0185","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.arcmed.2013.01.007","article-title":"Increased risk of type 2 diabetes in subjects with both elevated liver enzymes and ultrasonographically diagnosed nonalcoholic fatty liver disease: a 4-year longitudinal study","volume":"44","author":"Choi","year":"2013","journal-title":"Arch Med Res"},{"key":"10.1016\/j.dld.2017.12.018_bib0190","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1111\/liv.12851","article-title":"Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi'an, China: a five-year cohort study","volume":"35","author":"Ming","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2017.12.018_bib0195","doi-asserted-by":"crossref","first-page":"9607","DOI":"10.3748\/wjg.v21.i32.9607","article-title":"Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus","volume":"21","author":"Li","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2017.12.018_bib0200","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2015.07.018","article-title":"Liver fat, statin use, and incident diabetes: the Multi-Ethnic Study of Atherosclerosis","volume":"242","author":"Shah","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.dld.2017.12.018_bib0205","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/07853890.2010.518623","article-title":"Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity","volume":"43","author":"Musso","year":"2011","journal-title":"Ann Med"},{"key":"10.1016\/j.dld.2017.12.018_bib0210","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/jgh.13264","article-title":"Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis","volume":"31","author":"Ballestri","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2017.12.018_bib0215","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.28839","article-title":"Nonalcoholic steatohepatitis in non-obese patients: not so different after all","volume":"65","author":"Cusi","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2017.12.018_bib0220","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.dld.2014.09.020","article-title":"Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome","volume":"47","author":"Lonardo","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2017.12.018_bib0225","doi-asserted-by":"crossref","first-page":"9674","DOI":"10.3748\/wjg.v22.i44.9674","article-title":"Fatty liver is associated with an increased risk of diabetes and cardiovascular disease\u2014evidence from three different disease models: NAFLD, HCV and HIV","volume":"22","author":"Lonardo","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2017.12.018_bib0230","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","article-title":"Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB","volume":"11","author":"Cai","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.dld.2017.12.018_bib0235","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrendo.2012.258","article-title":"The role of hepatokines in metabolism","volume":"9","author":"Stefan","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.dld.2017.12.018_bib0240","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2337\/diacare.29.04.06.dc05-1938","article-title":"Alpha2-Heremans-Schmid glycoprotein\/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans","volume":"29","author":"Stefan","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dld.2017.12.018_bib0245","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.2337\/db08-0538","article-title":"Plasma fetuin-A levels and the risk of type 2 diabetes","volume":"57","author":"Stefan","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.dld.2017.12.018_bib0250","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1872-034X.2012.01031.x","article-title":"Liver and diabetes. A vicious circle","volume":"43","author":"Loria","year":"2013","journal-title":"Hepatol Res"},{"key":"10.1016\/j.dld.2017.12.018_bib0255","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3390\/ijms17030355","article-title":"Type 2 diabetes in non-alcoholic fatty liver disease and hepatitis C virus infection\u2014liver: the musketeer in the spotlight","volume":"17","author":"Ballestri","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dld.2017.12.018_bib0260","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.2337\/dc15-0140","article-title":"Independent association between improvement of nonalcoholic fatty liver disease and reduced incidence of type 2 diabetes","volume":"38","author":"Yamazaki","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dld.2017.12.018_bib0265","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.cgh.2017.04.045","article-title":"Liver and cardiovascular damage in patients with lean nonalcoholic fatty liver disease, and association with visceral obesity","volume":"15","author":"Fracanzani","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2017.12.018_bib0270","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/hep.28697","article-title":"Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients","volume":"65","author":"Leung","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2017.12.018_bib0275","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/apt.12963","article-title":"Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease","volume":"40","author":"Fedchuk","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2017.12.018_bib0280","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.metabol.2017.04.003","article-title":"Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic\/histological parameters in various liver diseases","volume":"72","author":"Ballestri","year":"2017","journal-title":"Metabolism"},{"key":"10.1016\/j.dld.2017.12.018_bib0285","doi-asserted-by":"crossref","first-page":"27034","DOI":"10.1038\/srep27034","article-title":"Association of non-alcoholic fatty liver disease with metabolic syndrome independently of central obesity and insulin resistance","volume":"6","author":"Yang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2017.12.018_bib0290","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1478-3231.2012.02804.x","article-title":"Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD","volume":"32","author":"Ballestri","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2017.12.018_bib0295","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1210\/jc.2015-1966","article-title":"High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels","volume":"100","author":"Portillo-Sanchez","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.dld.2017.12.018_bib0300","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/jhep.2003.50229","article-title":"Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values","volume":"37","author":"Mofrad","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2017.12.018_bib0305","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.22429","article-title":"Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes","volume":"48","author":"Fracanzani","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2017.12.018_bib0310","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jhep.2013.05.044","article-title":"From NAFLD in clinical practice to answers from guidelines","volume":"59","author":"Nascimbeni","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2017.12.018_bib0315","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2017.12.018_bib0320","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-230X-12-2","article-title":"Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population","volume":"12","author":"Sumida","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.dld.2017.12.018_bib0325","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jhep.2016.04.023","article-title":"Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease","volume":"65","author":"Boursier","year":"2016","journal-title":"J Hepatol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086581731335X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086581731335X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T22:21:46Z","timestamp":1535149306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S159086581731335X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S159086581731335X"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2017.12.018","relation":{},"ISSN":["1590-8658"],"issn-type":[{"type":"print","value":"1590-8658"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2017.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}